31.2 C
New York
Thursday, July 3, 2025

Tag: press release

BAB, Inc. Reports Results for 2nd Quarter FY 2025

DEERFIELD, Ill., July 03, 2025 (GLOBE NEWSWIRE) -- BAB, Inc. (OTCQB: BABB), announced its financial results for the second quarter ended May 31, 2025.

Actelis Networks Announces Closing of Private Placement Priced At-the-Market under Nasdaq Rules

FREMONT, Calif, July 03, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,626,019 shares of its common stock, Series A-3 warrants to purchase up to an aggregate of 1,626,019 shares of common stock and short-term Series A-4 warrants to purchase up to an aggregate of 3,252,038 shares of common stock, at a purchase price of $0.615 per share and associated warrants.

Vestis Corporation (VSTS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, July 3, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Vestis Corporation ("Vestis" or...

CoreWeave Becomes First Hyperscaler to Deploy NVIDIA GB300 NVL72 Platform

LIVINGSTON, N.J., July 3, 2025 /PRNewswire/ -- CoreWeave (Nasdaq: CRWV), the AI Hyperscaler™, today announced it is the first AI cloud provider to deploy the latest...

European savings and retirement services group Athora to acquire Pension Insurance Corporation Group

Ownership of Pension Insurance Corporation Group ("PICG"), ultimate parent company of the specialist insurer of UK defined benefit pension schemes Pension Insurance Corporation ("PIC"),...

CapsoVision Announces Closing of Initial Public Offering

SARATOGA, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (“AI”) technologies that are deployed in its capsule endoscopy solutions, today announced the closing of its initial public offering of 5,500,000 shares of common stock at a public offering price of $5.00 per share. The shares began trading on the Nasdaq Capital Market on July 2, 2025 under the ticker symbol “CV.”

BexBack Launches Limited-Time $50 Bonus, 100% Deposit Bonus Match, 100x Leverage, and No KYC Amid Bitcoin Surge Past $100K

SINGAPORE, July 03, 2025 (GLOBE NEWSWIRE) -- With Bitcoin fluctuating above the $100,000 mark, many analysts predict that the cryptocurrency market will remain in a state of high volatility for the long term. In such a scenario, holding spot positions may struggle to generate short-term profits. As a result, 100x leverage futures trading has become the preferred tool for experienced investors seeking to maximize potential returns in this turbulent market.

Lifeway Foods Comments on Edward and Ludmila Smolyansky’s Consent Solicitation and Urges Shareholders to Disregard the Unlawful Consent Solicitation Statement

MORTON GROVE, Ill., July 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ: LWAY) ("Lifeway" or the "Company"), a leading U.S. supplier of Kefir and fermented...

Boldyn Networks named a Major Player in IDC MarketScape for European Enterprise Private 5G Solutions

LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as a Major Player...

Boldyn Networks named a Major Player in IDC MarketScape for European Enterprise Private 5G Solutions

LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as a Major Player...

DeFi Development Corp. Purchases 17,760 SOL, Resumes SOL Accumulation Strategy

BOCA RATON, FL, July 03, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), announced today the purchase of 17,760 Solana (“SOL”) at an average purchase price of $153.10 and valued at approximately $2.72 million. Following the transaction, DeFi Development Corp. now holds a total of approximately 640,585 SOL and SOL equivalents, valued at approximately $98.1 million, inclusive of staking rewards.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has received Institutional Review Board (IRB) approval from Tel Aviv Sourasky Medical Center (TASMC) in Tel Aviv, Israel, for its ongoing Phase 1/2a clinical trial evaluating CMND-100, a proprietary MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). This approval will enable patient enrollment at TASMC, a leading clinical site in Israel, prior to commencing this first-in-human trial at the site.

Stuhini Highlights High-Grade Tungsten Potential at Ruby Creek

VANCOUVER, BC, July 3, 2025 /CNW/ - Stuhini Exploration Ltd. (the "Company" or "Stuhini") (TSX-V: STU and OTCQB: STXPF) is pleased to report the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress release